GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (TSX:SVA) » Definitions » EV-to-EBIT

Sernova (TSX:SVA) EV-to-EBIT : -1.87 (As of May. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Sernova EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sernova's Enterprise Value is C$76.11 Mil. Sernova's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was C$-40.69 Mil. Therefore, Sernova's EV-to-EBIT for today is -1.87.

The historical rank and industry rank for Sernova's EV-to-EBIT or its related term are showing as below:

TSX:SVA' s EV-to-EBIT Range Over the Past 10 Years
Min: -100.79   Med: 0   Max: 0
Current: -1.87

TSX:SVA's EV-to-EBIT is ranked worse than
100% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs TSX:SVA: -1.87

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Sernova's Enterprise Value for the quarter that ended in Jan. 2024 was C$176.18 Mil. Sernova's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 was C$-40.69 Mil. Sernova's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 was -23.10%.


Sernova EV-to-EBIT Historical Data

The historical data trend for Sernova's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova EV-to-EBIT Chart

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.93 -9.92 -43.28 -7.95 -5.41

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.48 -7.79 -6.92 -5.41 -4.33

Competitive Comparison of Sernova's EV-to-EBIT

For the Biotechnology subindustry, Sernova's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sernova's EV-to-EBIT falls into.



Sernova EV-to-EBIT Calculation

Sernova's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=76.107/-40.693
=-1.87

Sernova's current Enterprise Value is C$76.11 Mil.
Sernova's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-40.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova  (TSX:SVA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sernova's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jan. 2024 ) =EBIT / Enterprise Value (Q: Jan. 2024 )
=-40.693/176.18379
=-23.10 %

Sernova's Enterprise Value for the quarter that ended in Jan. 2024 was C$176.18 Mil.
Sernova's EBIT for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-40.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sernova's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (TSX:SVA) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.
Executives
Jeffrey Bacha Director

Sernova (TSX:SVA) Headlines

From GuruFocus

SINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa

By Business Wire Business Wire 06-25-2022